{"url_path":"/sec/ostx/8-k/2026-07-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1795091/0001213900-26-075013-index.html","accession_number":"0001213900-26-075013","cik":"0001795091","ticker":"OSTX","issuer_name":"OS Therapies Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1795091/0001213900-26-075013-index.html","primary_entity_key":"0001795091","primary_entity_name":"OS Therapies Inc"},"word_count":196,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n*(d) Exhibits.*\n\n* *\n\n**Exhibit\nNumber  **\n \n**Description  **\n\n4.1*\n \n[Form of Senior Secured Convertible Promissory Note.](ea029686801ex4-1.htm)\n\n4.2\n \n[Form of Common Stock Purchase Warrant.](ea029686801ex4-2.htm)\n\n10.1*\n \n[Securities Purchase Agreement, dated as of June 30, 2026, among OS Therapies Incorporated, OS Animal Health Inc., OS Therapies UK LTD and Leonite Fund I, LP.](ea029686801ex10-1.htm)\n\n10.2\n \n[Pledge and Security Agreement, dated as of June 30, 2026, among OS Therapies Incorporated, OS Animal Health Inc., OS Therapies UK LTD and Leonite Fund I, LP.](ea029686801ex10-2.htm)\n\n99.1\n \n[Press Release issued by OS Therapies Incorporated on July 2, 2026.](ea029686801ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n*Pursuant to Item 601(a)(5) of Regulation S-K, certain schedules\nand exhibits have been omitted. The registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC\nupon its request.\n\n \n\n6\n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \n**OS THERAPIES INCORPORATED**\n\n \n \n\nDated: July 2, 2026\nBy:\n/s/ Paul A. Romness, MPH\n\n \n \nName:\nPaul A. Romness, MPH\n\n \n \nTitle:\nPresident and Chief Executive Officer\n\n \n\n7"}